This article first appeared on GuruFocus .
-
Total Revenue:RMB720 million for the first half of 2026.
-
Net Profit:GAAP net profit attributable to common shareholders increased to RMB25.3 million.
-
Total GWP Facilitated:Reached a record high of RMB4.2 billion, up 29.8% year-over-year.
-
Total FYP:Surged 48.7% year-over-year to RMB2.76 billion.
-
Long-term Savings Product FYP:Rose more than 45% year-over-year to RMB2 billion.
-
Long-term Health Insurance FYP:Grew 1.6x year-over-year to RMB204 million.
-
Short-term Health and Accident Insurance FYP:Grew 48% year-over-year to RMB376 million.
-
2A Business FYP:Increased by 44% year-over-year to RMB2,116 million.
-
Operating Expenses:Decreased to RMB175 million, resulting in an improved expense-to-income ratio of 24.2%.
-
Cash and Cash Equivalents:Totaled RMB241 million as of June 30.
-
International Revenue:Approximately RMB220 million in the first half.
-
Vietnam (Global Care) GWP:Increased approximately 45% year-over-year.
-
Vietnam (Global Care) Revenue:Increased 24% year-over-year.
-
Average Ticket Size (Long-term Savings Products):Rose 10.4% year-over-year to RMB140,500.
-
Average FYP Ticket Size (Long-term Insurance Products):Increased 25% year-over-year to approximately RMB8,211.
-
New Customers Added:Approximately 798,000 in the first half, bringing cumulative insurance clients to approximately 13.1 million.
-
Persistency Ratios:13th and 25th month persistency ratios remained about 95% as of May 31.
-
Repurchase Ratio:Remained high at 33.3% for long-term insurance products.
Release Date: August 20, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Huize Holding Ltd ( NASDAQ:HUIZ ) achieved record GWP facilitation of RMB4.2 billion, up 30% year-over-year, with FYP surging 49% to RMB2.76 billion.
-
The company's AI-native strategy is driving tangible results, including a 65% increase in AI conversation users and a 45% planning report generation rate among active users.
-
International expansion is gaining traction, with Vietnam's Global Care seeing GWP and revenue growth of 45% and 24% year-over-year, respectively, and Hong Kong already profitable.
-
Customer quality remains high, with 13th and 25th month persistency ratios at approximately 95%, and the average FYP ticket size for long-term insurance products increasing 25% year-over-year.
-
Operating efficiency improved significantly, with total operating expenses decreasing to RMB175 million and the expense-to-income ratio improving to 24.2%.
Negative Points
-
Net profit margin remains relatively low at RMB25.3 million, partly due to continued heavy investment in AI, with R&D and CapEx expected to remain around $10 million annually.
-
The Vietnam business is still not EBITDA positive, though losses are minimal, indicating ongoing investment needs in high-growth markets.
-
Regulatory uncertainties, such as the potential enforcement of a 20% tax on overseas insurance product dividends, could impact customer sentiment in the Hong Kong and Macau business.
-
The company's valuation is currently low, which may limit its ability to raise capital for transformative M&A opportunities without diluting shareholders.
-
Singapore operations, which started in Q4 2025, are still ramping up and have yet to achieve profitability, adding to near-term financial drag.
Q & A Highlights
Q: Can you provide tangible examples of the returns from your AI investments, such as lower customer acquisition costs, higher conversion, improved agent productivity, or lower operating costs? Where do you see the most benefit? A: Co-CFO Ronald Tam explained that the first phase of AI adoption focuses on automating workflows and deploying AI agents across the value chain, which has already led to a lower operating expense ratio. The second phase is driving front-end growth, evidenced by an increasing number of self-directed policy purchases via AI consultations in the mobile app. This is improving conversion rates and agent productivity, as the same headcount is producing more premium growth.
Q: Can you discuss the profitability of your international markets in Hong Kong, Singapore, and Vietnam individually, and what does the path to consolidated margin expansion look like? A: Co-CFO Ronald Tam stated that Hong Kong has been profitable since last year and is contributing to the bottom line. The Singapore business, which started in Q4 of last year, is expected to drive profitability this year. Vietnam is in a high-growth phase and is close to profitability, though not yet EBITDA positive, with minimal losses. The relatively low net profit margin is due to continued investment of cash flow into AI, totaling around $10 million in R&D and CapEx this year.
Q: What is your capital allocation strategy, and will you need to raise any cash in the next 12 to 18 months? A: Co-CFO Ronald Tam indicated that AI is the focus of organic investment. The company is unlikely to pursue further market expansion in the next 12 to 24 months and will instead scale existing businesses. Given the decent cash on the balance sheet and the company's relatively low valuation, it is unlikely to raise capital unless a major transformative M&A opportunity arises.
Q: After the news regarding the 837 regulation and media reports on tax authorities charging 20% tax on product dividends, has Huize observed any changes in customer demand for overseas and domestic business? A: Co-CFO Ronald Tam clarified that market sentiment and momentum, particularly in Hong Kong, remain robust based on July and August data. He noted that the context of the media article is not new and has long been part of Chinese regulations; it is a matter of future enforcement. The underlying demand for offshore insurance remains intact due to the attractiveness of international asset allocation and the prevailing low-interest-rate environment in China.
Q: Can you elaborate on the growth drivers behind the strong first-half 2026 results, particularly in the long-term savings and health insurance categories? A: Co-CFO Ronald Tam highlighted that FYP from long-term savings products rose over 45% year-over-year to RMB2 billion, driven by heightened demand for wealth management in a low-interest-rate environment. FYP for long-term health insurance grew 1.6x year-over-year to RMB204 million, supported by policy initiatives like the National Commercial Health Insurance Innovative Drug Catalog. The company's omnichannel distribution network and AI technologies were key to broadening customer reach.
Q: What are the key operational achievements that demonstrate the effectiveness of your AI strategy and customer engagement? A: Co-CFO Ronald Tam noted that FYP for the 2A business increased 44% year-over-year to RMB2,116 million, underscoring AI's role in improving productivity for in-house consultants and IFA partners. FYP from short-term health and accident insurance grew 48% to RMB376 million. The 13th and 25th-month persistency ratios remained above 95%, and the average ticket size for long-term savings products rose 10.4% to RMB140,500, partly due to higher-ticket premium products in international markets.
Q: How is the company's AI-native strategy evolving beyond operational efficiency to drive business growth? A: CEO Chen Junma (via opening remarks) explained that the AI app was upgraded to a 2.0 multi-agent architecture, with users engaging in AI conversations increasing 65% from the beginning of the year. AI is becoming a key gateway for insurance consultation and planning, with family insurance plans generated in under 5 minutes. AI-powered outbound calls and intelligent screening are identifying cross-selling opportunities, evolving AI into an engine for business growth. On the claims side, end-to-end AI processing can now be completed within one hour.
Q: What is the outlook for the second half of 2026, and what are the company's strategic priorities? A: CEO Chen Junma outlined three priorities: advancing the AI-native strategy to deepen adoption and practical impact; strengthening customer-driven product innovation, particularly in participating insurance and long-term health products; and deepening international operations through Poni Inshi Tag in key Asian markets, leveraging Hong Kong and Singapore as regional hubs. The company remains focused on sustainable business value and long-term growth.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
